chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few hours after the vaccine, came home and got a headache, then she got nausea.  She went to bed, and all night and into the next day had fever/chills.  She got up during the night to get some water she collapsed and could not get up as she was so weak.  Her husband found her and helped her back to bed.  Today, 2/22/21 she is better today and feels almost to normal.   She took Pepto-Bismol for the nausea.   Tylenol/Ibuprofen did not take the headache, but it did finally go away.   The headache was on the top of her head.
Patient was accidentally likely given a higher dose of pfizer covid vaccine than recommended for her age group. Patient is and has been asymptomatic since vaccination.
immune compromised; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 78-year-old patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE SYSTEM DISORDER (non-serious), outcome "unknown", described as "immune compromised".  The information on the batch/lot number for [RSV VACCINE PROT.SUBUNIT PREF 2V] has been requested and will be submitted if and when received.
generalized weakness, fatigue, dry cough, decrease appetite and congestion with recent diagnosis of COVID-19.  While in the emergency department she had oxygen saturation dropped to 86% and sustain for a long period that she was placed on 1-2 L
RECEIVED 1ST DOSE OF PFIZER COVID-19 VACCINE ON 02/12/21 ON 02/20/21 REPORTED TO ED AFTER BECOMING LIGHT HEADED AND HAVING A SYNCOPAL EPISODE. REPORTED SOME SOA ON EXERTION THAT DEVELOPED EARLIER THAT DAY.  ON 02/20/21 PT ADMITTED INPATIENT TO HSOPITAL WITH DIAGNOSIS OF SYNCOPE AND COLLAPSE, AOMMUNITY AQUIRED PNEUMONIA, ACUTE COLITIS, AND LEUKOCYTOSIS.
I had no symptoms that I could feel. However I did notice the splotches on my lower legs. They are pretty large, 2-3 inches wide. They look like kind of round red patches. Now they're fading but the areas are still visible even though they're not as red as they used to be. Those occurred on both legs. Roughly where you wear socks with elastic on both sides mostly towards the inner legs towards the back. If you go up where the muscle is on the calf. I can still see there even though they're not as prominent. I did go to my doctor but they did not advise for any treatment. Note: My mother also had a reaction with the vaccine with red capillary veins being prominent right after vaccination in arm and hand. Unsure if this is a genetic reaction.
pt recvd vax 2nd dose of vax 29AUG95 & lab eval 27SEP95 revealed that pt was again neg for varicella antibody;16OCT95 pt was administered 3rd dose;no further details were provided;
Information has been received from a nurse concerning a female who on 19-FEB-2008 was vaccinated with the third dose of GARDASIL. On the same day, after receiving her third dose, the patient passed out in the office and experienced syncope. Subsequently, the patient recovered fully from syncope on the same day. The patient saw the nurse practitioner. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning his 4 year old daughter who in the summer of 1998 was vaccinated with a dose of varicella virus vaccine live.  In July 1999 the patient developed chickenpox.  The patient was treated with diphenhydramine.  Subsequently, the patient recovered.  No product quality complaint was involved.  It was also reported that a male patient was vaccinated with a dose of varicella virus vaccine live and developed chickenpox.  Additional information has been requested.
Information has been received from an 82 year old male pharmacist referring to himself. The patient had multiple unspecified pertinent medical history and unspecified drug reactions/allergies. On 04-DEC-2015 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, dose and strength unknown) intramuscularly. Concomitant medication included multiple unspecified medications. On 05-DEC-2015, the patient began to experience redness, pain and slight swelling around the injection site which extended about one to two inches beyond the injection site. The patient reported that the injection site also felt warm to touch. On 08-DEC-2015, the patient went back to see the physician who administered the vaccine and the physician told him to rub BENADRYL cream on the injection site every 4-5 hours as needed for the itching and swelling. The outcome of the events was unknown. Causality was not provided. Additional information has been requested.
hypertension; Acid reflux; Muscle pain in my legs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal) and Blood pressure high (Blood pressure).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs). At the time of the report, HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: higher (High) Higher.         No concomitant medications were provided. Treatment medications were unknown.
No initial reaction. About a month later, I started experiencing chronic urticaria which is ongoing. After initially trying to treat at home, I saw my PCP who ran some tests, and since then I've been working with an allergist who says it's a hyper immune response. (I checked off "permanent damage" below because the problem is ongoing.)
hospitalized 9/28/21 with shortness of air, SARS-CoV-2 positive 9/28/21.  Multiple high risk comorbidities for severe COVID-19 disease including type 2 diabetes mellitus, chronic obstructive pulmonary disease, obstructive sleep apnea on nocturnal CPAP, and atherosclerotic coronary vascular disease with previous coronary artery bypass grafting.  Brought to ER after calling paramedics with increasing shortness of breath.  O2 saturation on room air in the emergency department 84%.  Symptomatic over the last 8 days with increasing cough and exertional dyspnea.  Patient reports green purulent sputum production.  Unaware of hemoptysis.  Failed on pulmonary appointment with Dr.  The patient's wife died of acute respiratory failure 1 week ago.  It is uncertain as to whether or not this was Covid related.  Chest x-ray in the emergency department with interstitial infiltrates predominant late in a lower lobe distribution consistent with COVID-19
Red, swollen, area in auxcillary region of right arm. Warm to touch. Rand-Aid present over injection sight in right deltoid. Probable allergic reactions but possible cellulitis.
Vaccines were administered following a temperature excursion; there were no adverse reactions; This spontaneous report was received from a vaccine coordinator/administrator and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided.  On an unknown date, the patient was vaccinated with improperly stored dose (product storage error) of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose number, dose, route of administration, lot # and expiration date were not reported) for prophylaxis.  It was reported that the vaccine was stored in the temperature of 48 Fahrenheit (F) for a time frame of 1 hour and 2 minutes without a previous temperature excursion. There were no adverse reactions (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2110USA003600: US-009507513-2109USA001290: US-009507513-2110USA003605: US-009507513-2110USA003601: US-009507513-2110USA003603: US-009507513-2110USA003602: US-009507513-2110USA003599:
No adverse event; 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023).    No concomitant medications were reported. The vial was initially thawed on 10-Jun-2023.  Treatment medications were not reported.  This case is for 25th patient out of 30 patients reported by reporter.    This case was linked to US-MODERNATX, INC.-MOD-2023-732645 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live significant follow-up received: Drug start date was updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732645:Master case (Patient 1)
This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (Not been able to eat), RETCHING (Dry heaving), ILLNESS (Sickness) and PYREXIA (Running a fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer COVID19 Vaccine (first dose; lot EJ1685) on 04-Jan-2021 and Pfizer COVID19 Vaccine (second dose;lot EL3302) on 25-Jan-2021.Past adverse reactions to the above products included No adverse event with Pfizer COVID19 Vaccine and Pfizer COVID19 Vaccine.On 18-Nov-2021 at 11:30 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced FEEDING DISORDER (Not been able to eat), RETCHING (Dry heaving) and PYREXIA (Running a fever). 18-Nov-2021, the patient experienced ILLNESS (Sickness). At the time of the report, FEEDING DISORDER (Not been able to eat), RETCHING (Dry heaving), ILLNESS (Sickness) and PYREXIA (Running a fever) outcome was unknown. Concomitant product use was not provided by the reporter.Treatment information was not provided.Around 6 o'clock in the evening, the patient had been sick. The patient was not been able to eat, running a fever and had dry heaving.
Possible seizure parents called EMS and was transported to ER parents stated they were waiting to long and went home with out being seen by a doctor.
CLIENT AFTER SEVEN MINUTES FROM BEING VACCINATED AND WHILE SITTING DOWN FOR 15 MIN OBSERVATION ALMOST FELL DOWN FROM A SITTING POSITION DUE TO A SYNCOPE. CLIENT SITTING NEXT TO HER REPORTED THAT SHE WAS OVER HER SHOULDER FOR ABOUT A MINUTE. CLIENT STATED THAT SHE FELT LIKE SHE WAS GETTING SLEEPY AND TIRED. CLIENT COMPLAINED OF DIZZINESS, BLURRED VISION AND WEAKNESS. CLIENT WAS OBSERVED FOR 45 MIN WITH A NORMAL B/P AND PULSE. INDICATED CLIENT TO VISIT MD IS NECESSARY.
felt weird 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt weird 3-4 days) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included OXYCODONE and ALPRAZOLAM (XANAX) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt weird 3-4 days). At the time of the report, FEELING ABNORMAL (felt weird 3-4 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. No treatment information was provided.   This case was linked to MOD-2021-053415 (Patient Link).
Nonocclusive thrombosis of the right transverse sinus extending to the sigmoid sinus. This is most significant in the transverse sinus where there is 70% stenosis. Findings are new compared to prior CTA from 2014.    I've never had a clot in my life....anywhere.  53 days after my 2nd covid vaccine shot, I have a 70% blockage in my brain.
This spontaneous report as received from a pharmacy technician on behalf of nurse refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with (Oka/Merck) VARIVAX (subcutaneous, dose was unknown) instead of (Oka/Merck) ZOSTAVAX. Pertinent medical history and concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. No additional information has been requested.
Initial misuse report received from a healthcare professional on 24 January 2014. A '04-month-old' patient (No information was provided regarding the patient) had received a dose of FLUZONE) on an unspecified date, and no adverse event was reported. i,e, inappropriate age at vaccine administration. List of documents held by sender: none. This case is linked with case number: 2014SA046378.
client received 3rd dose of Pfizer BIONTech COVID19 vaccine at 1450. At 1455 father/mother report syncopal episode with "seizure like" movement. Client noted to be pale, diaphoretic, shallow and even respirations, conscious with c/o SOB, unable to obtain BP with manual cuff, unable to obtain SpO2 R/T coldness of hands, lungs CTAB, pulse weak and regular. Administered Epi-Pen 0.3mg IM to LVL x 1 and Benadryl 50mg IM to RVL x 1, patient transported to ER for evaluation, report to ER staff at 1500.
10 minutes following administration of vaccination to right deltoid, individual complained of a "tight" sensation in throat but said it did not affect her breathing. Individual denied shortness of breath/ difficulty breathing, pain, or any other symptoms. 12.5mg Benadryl in 15ml elixir given orally to individual. Vital signs taken and patient monitored. No signs of distress noted. Additional 12.5mg Benadryl in 15ml elixir given approx 45 minutes later. Individual monitored for a total of 90 minutes. Individual stated that the "tight" feeling was subsiding and starting to going away. After 90 minutes of monitoring, individual left and states tightness had subsided.
Patient received third dose without being immunocompromised; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Patient received third dose without being immunocompromised) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   In January 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced OFF LABEL USE (Patient received third dose without being immunocompromised). At the time of the report, OFF LABEL USE (Patient received third dose without being immunocompromised) had resolved.            No Concomitant product use was reported. No treatment information was provided  It was reported that the patient received their first dose of the Moderna vaccine in Jan-2021 and second dose in Feb-2021 and received the third dose without consulting their healthcare provider on whether the patient was immunocompromised or not. Reportedly, the patient had diabetes.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 21-SEP-2015, the patient was vaccinated with an improperly stored PNEUMOVAX 23 10 PK, lot # L002310, expiration date 08-JUL-2016, at a dose of 0.5 ml, (route and anatomical location of administration were unspecified). The vaccine underwent a total temperature excursion, of 648 hours. The lowest recorded temperature was 27 Fahrenheit degrees (-2.777777778 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
brief ache in arm went away overnight, left side from thigh to knee muscles/ joint pain, hard to get up
Period was extremely heavy with spotting in between periods after first shot. When went for second shot I mentioned my period changes and the women said she had never heard of someone?s period being effected. I still am having the same issues extremely heavy flows with spotting in between periods almost every week.
Hives all over body, onset 4 days after vaccine,  persisted at least 2 days, had resolved at time of telephone followup on 8/11
Pfizer Lot EW0185 time Vax received: 3:29pm - Adverse Reaction - 3:40pm dizziness, nauseated. vitals taken at 3:41pm B/P 142/88 H: 91 R18 Oxy 99 - 3:46 B/P: omitted  H:93 R: 18 Oxy 99%. Discharged 3:52pm left on her own allergic of penicillin- ate breakfast 8:30am missed lunch.
Presented to ED by her husband because of multiple falls over the last week.  She has had some progressive SOB over last week and has no home oxygen.  EMS reported saturation of 87%, placed on 6 LNC.  She c/o all over body pain and found to be covid positive.  Chest xray shows infiltrates in both lungs.  Patient had became bradycardic that progressed to asystole, and code blue was called in the ED.  Patient had 5 rounds of CPR with epinephrine and hat ROSC.  However, patient became bradycardic, atropine given, and patient coded again and was unable to regain a pulse.  Patient expired on 09/07/2021.
Pt recvd 1st dose of Hep B vax & devel sneezing & watery eyes; pt later devel abdominal cramps, thick tongue, tingling in hands, severe dizziness, lethargy, weakness, chest pain, voices sound far away; poss sz;
This spontaneous report as received from a consumer and refers to her mother's aunt, a 91-year-old female patient. The patient had a medical history of Epstein-Barr virus infection. The patient's concurrent conditions, concomitant medications and drug reactions/ allergies were not reported. On an unspecified date, the patient was vaccinated with a dose of an unspecified pneumonia vaccine (manufacturer unknown) (captured as PNEUMOVAX23) and a dose of an influenza virus vaccine at the same time for prophylaxis (dose number, route, and lot # were not reported). On the same day at night, the patient passed away. The cause of death was not reported. It was unknown, if an autopsy was performed. The reporter's causality assessment was not provided. This was one of two reports received from a same reporter.; Sender's Comments: US-009507513-1809USA010075:; Reported Cause(s) of Death: Unknown cause of death.
within 12 hours - chills next 48 hours - headache, feverish, hot flashes, nausea, vomiting, extreme fatigue another 24 hours - headache, fatigue
This 46-month-old female received 4 doses of Haemophilus b conjugate vax. Subsequent to the 4th vax on 01/02/1993, she experienced bacteremia related to vax failure. Haemophilus influenzae type B was indicated by a blood specimen. Upon medical review, the pt's experience was considered to be an "other medical events."  The reporter indicated that the pt "survived" the experience. Additional information has been requested.
No further adverse effect reported; a patient received a dose of improperly stored ROTATEQ; This spontaneous report was received from a Medical Assistant who referred to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, as well as drug reactions or allergies, were not provided.   On 19-FEB-2020, the patient was inadvertently administered with  an improperly stored dose (product storage error) of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 1 dose orally for prophylaxis (strength not reported)(lot number S014947 had been verified to be valid lot numbers; expiration date 10-DEC-2020). The  temperature  excursion was at below 36 degrees Fahrenheit (34 F), for a time frame of 27 minutes, and  no had previous temperature excursion. It was reported that the call was due to data logger. No adverse effects were reported.; Sender's Comments:  US-009507513-2002USA010005: US-009507513-2002USA009991:
This case was reported by a female physician in her 40's who did not respond to the hep A vaccine inactivated (Havrix) for prophylaxis. On 01Dec04 the pt received the 1st dose of Havrix. Subsequently, on 12Jan05, a hep A antibody titer was negative.
Have had Veritgo  and other dizziness since the 2nd vaccine on March 12,2021
I got home and I had a severe headache that would not go away. I was taking Advil and Tylenol which did not help. I ended up calling the doctor the following Wednesday, he said to drink plenty of water, and he prescribed muscle relaxer Flexeril and Phenergan. My symptoms would not go away so I called the doctor again and they said they couldn't do anything else for me that I needed to call the neurologist and make an appointment. I am scheduled to see neuro on July 29th Neurology. I am dealing with mouth sores that have developed, I have had them around 10 days, I have been swishing with salt water. I have also experienced burning in my throat and still have headaches.
Complaining of headache and eye aches, malaise, post vax, Anthrax vaccine.